maintenance tirzepatide for of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial What Is the Ideal Tirzepatide

2020 Mar 26;5(6):e133429

They try to focus more on lifestyle habits, such as increased physical activity, a reduced-calorie diet, and exercise, rather than on weekly injections

While GLP-1 medications do not directly cause frequent urination, several indirect mechanisms may explain why some individuals notice changes in their urinary patterns after starting treatment

The FDA stated it received an unspecified number of adverse event reports linked to compounded semaglutide that were due to dosing errors

These are typically transient and fade within a few weeks

In summary, there is robust evidence that GLP-1 agonist therapy favorably impacts the trajectory of cardiovascular disease across the spectrum of severity